COMPUGEN LTD — insider transactions
24 transactions on record · CGEN · CIK 1119774
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
24
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
12
Bought, 3m
$0
Sold, 3m
$6.2K
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$4.7K
2026-07-09
Director share, 12m
50.0%
of transactions where role is stated
Current run
24 sells
consecutive same-direction transactions
Net 3m flow
-$6.2K
purchases minus sales
Total on record
24
Transactions
24 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | 2026-07-29 | 1 | Mahler Michelle | Chief Medical Officer | Grant or award | 13,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | ZWEIFACH SANFORD S | Director | Grant or award | 10,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Halevy Gilead | Director | Grant or award | 10,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | ZWEIFACH SANFORD S | Director | Grant or award | 7,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Hukkelhoven Mathias | Director | Grant or award | 7,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Livnat Savitzky Kinneret | Director | Grant or award | 10,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Ferre Pierre | Chief Operating Officer | Grant or award | 70,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Cohen-Dayag Anat | Director | Grant or award | 100,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Silberman David | Chief Financial Officer | Grant or award | 26,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Mahler Michelle | Chief Medical Officer | Grant or award | 18,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Halevy Gilead | Director | Grant or award | 7,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Hukkelhoven Mathias | Director | Grant or award | 10,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Kredo Russo Sharon | SVP, Research & Discovery | Grant or award | 18,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Perry Eran | Director | Grant or award | 7,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Ophir Eran | Director, President and CEO | Grant or award | 200,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Levine Zurit | SVP, Business Development | Grant or award | 24,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Livnat Savitzky Kinneret | Director | Grant or award | 7,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Kredo Russo Sharon | SVP, Research & Discovery | Grant or award | 24,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Perry Eran | Director | Grant or award | 10,000 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Silberman David | Chief Financial Officer | Grant or award | 19,500 | $0.00 | — | filing |
| 2026-07-30 | 2026-07-29 | 1 | Levine Zurit | SVP, Business Development | Grant or award | 18,000 | $0.00 | — | filing |
| 2026-07-13 | 2026-07-09 | 4 | Levine Zurit | SVP, Business Development | Exercise of derivative | 1,875 | $0.83 | $1.6K | filing |
| 2026-07-13 | 2026-07-09 | 4 | Levine Zurit | SVP, Business Development | Open market sale | 1,875 | $2.50 | $4.7K | filing |
| 2026-07-13 | 2026-07-09 | 4 | Levine Zurit | SVP, Business Development | Exercise of derivative | 1,875 | $0.00 | — | filing |